Tilray acquires Natura Naturals Holdings for $52mn

By nat blo
Share

Medical and recreational cannabis research, cultivation, production and distribution firm Tilray Inc announced this week it has entered into a definitive agreement to acquire will acquire all of the issued and outstanding securities of Natura Naturals Holdings Inc, the parent company of a licensed cultivator of cannabis.

Tilray will deliver US$26.3mn upon completion of the deal, comprised of $11.2 mn in cash and $15mn in Tilray Class 2 common stock. Natura shareholders will receive their pro rata portion of the $11.2mn closing cash amount, following the deduction of transaction expenses and applicable tax. Following the closure of the deal, the remaining $26.3mn may become payable, depending on Natura’s ability to reach certain quarterly production milestones. If those requirements are reached, the final sale will be worth $52mn.

Upon closure of the deal, Tilray will acquire Natura’s 662,000 square-foot greenhouse cultivation facility, of which 155,000 square-feet are currently licensed, and all subsequent cannabis output from this facility.

SEE ALSO: 

Tilray’s revenue increased by 86% year-on-year in 2018, up to $10mn. In Q3 2018, the company sold sold 1,613 kilograms of cannabis.

“We’re very pleased to have an agreement in place that allows us to expand our capacity to supply high-quality branded cannabis products to the Canadian market,” said Brendan Kennedy, Tilray President and CEO. “Through an extensive and thorough search for the right supply partner, we’re pleased to have come to a mutually-beneficial agreement with Natura.”

The transaction is expected to close in the next 30 days.

 

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy